![Donald J. Kellerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald J. Kellerman
Keine laufenden Positionen mehr
Profil
Donald J.
Kellerman formerly worked at Glaxo Wellcome, Inc., as Director-Respiratory Clinical Research, Ciba-Geigy Corp., as Vice President-Cardiovascular Products, Sumitomo Pharma America, Inc., as Vice President-Clinical Research from 1996 to 1997, Inspire Pharmaceuticals, Inc., as Senior Vice President-Development from 1999 to 2008, MAP Pharmaceuticals LLC, as Senior VP-Clinical Development & Medical Affairs from 2011 to 2013, E.
R.
Squibb & Sons LLC, as Vice President-Cardiovascular Products, Zosano Pharma Corp., as VP-Clinical Development & Medical Affairs from 2015 to 2022, and Tonix Pharmaceuticals Holding Corp., as SVP-Clinical Development & Regulatory Affairs from 2014 to 2015.
Dr. Kellerman received his undergraduate degree and doctorate degree from the University of Minnesota.
Ehemalige bekannte Positionen von Donald J. Kellerman
| Unternehmen | Position | Ende |
|---|---|---|
| ZOSANO PHARMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2022 |
| TONIX PHARMACEUTICALS HOLDING CORP. | General Counsel | 01.04.2015 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Corporate Officer/Principal | 21.07.2008 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.1997 |
Ausbildung von Donald J. Kellerman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Ciba-Geigy Corp.
 Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
E. R. Squibb & Sons LLC | |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics | Health Technology |
Tonix Pharmaceuticals Holding Corp.
 Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
